Revenue:329 medal events. 32 sports. Endless drama. Catch all the action at the Paris OlympicsDexcom's revenue increased 15% from $871.3 million a year earlier, according to a release. The company reported net income of $143.5 million, up from the $115.9 million in the same period last year.
"The DME distributors remain important partners for us in our business, and we've not executed well this quarter against these partnerships," Sayer said on the call."We need to refocus on those relationships."had been cleared for use by the U.S. Food and Drug Administration. Stelo is designed for patients with Type 2 diabetes who do not use insulin. Dexcom said Thursday it will officially launch in August.
"I feel like there has to be more going on," Marcus said, and asked whether the surging popularity of GLP-1 weight-loss treatments is having an impact.